Literature DB >> 10553990

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias.

S M Papa1, R Desimone, M Fiorani, E H Oldfield.   

Abstract

The functional status of the globus pallidus internal segment (GPi) plays a key role in mediating the effects of antiparkinsonian drugs. During long-term levodopa therapy, patients develop abnormal movements, dyskinesias, the pathophysiological basis of which is poorly understood. We recorded single cells in the GPi of parkinsonian monkeys continuously through the "off" and "on" states, and 10 to 15 minutes later during "on with or without dyskinesias," depending on two doses of levodopa. The transition from the "off" to the "on" state was characterized by a decrease (most cells), no change, or an increase in firing rate of individual cells. During dyskinesias, firing rates declined profoundly in almost all cells, with decrements as low as 97% in individual cells. These changes occurred only when dyskinesias were present. The difference in GPi activity between "on" and "on with dyskinesias" suggests that normal motor function in Parkinson's disease critically depends on fine tuning of the basal ganglia output. Dyskinesias result from an imbalanced low GPi discharge, a circumstance that may be susceptible to development of new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553990     DOI: 10.1002/1531-8249(199911)46:5<732::aid-ana8>3.0.co;2-q

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

Review 1.  The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Authors:  Christopher A Lieu; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2011-09-24       Impact factor: 4.077

2.  Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.

Authors:  Christopher A Lieu; Milind Deogaonkar; Roy A E Bakay; Thyagarajan Subramanian
Journal:  Parkinsonism Relat Disord       Date:  2010-11-11       Impact factor: 4.891

3.  Coherence of neuronal firing of the entopeduncular nucleus with motor cortex oscillatory activity in the 6-OHDA rat model of Parkinson's disease with levodopa-induced dyskinesias.

Authors:  Xingxing Jin; Kerstin Schwabe; Joachim K Krauss; Mesbah Alam
Journal:  Exp Brain Res       Date:  2016-01-02       Impact factor: 1.972

Review 4.  Exendin-4 for Parkinson's disease.

Authors:  Felipe de Jesús Esparza-Salazar; Alma Rosa Lezama-Toledo; Germán Rivera-Monroy; Cesario V Borlongan
Journal:  Brain Circ       Date:  2021-03-30

Review 5.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

Review 6.  Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.

Authors:  Shigeki Hirano; Thomas Eckert; Toni Flanagan; David Eidelberg
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

7.  A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia.

Authors:  Allison E Girasole; Matthew Y Lum; Diane Nathaniel; Chloe J Bair-Marshall; Casey J Guenthner; Liqun Luo; Anatol C Kreitzer; Alexandra B Nelson
Journal:  Neuron       Date:  2018-02-01       Impact factor: 17.173

Review 8.  Update on models of basal ganglia function and dysfunction.

Authors:  Mahlon DeLong; Thomas Wichmann
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

9.  Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.

Authors:  Gali Heimer; Izhar Bar-Gad; Joshua A Goldberg; Hagai Bergman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

10.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.